XML 58 R42.htm IDEA: XBRL DOCUMENT v3.10.0.1
Benefit Plans (Tables)
12 Months Ended
Oct. 31, 2018
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Schedule of Share-Based Compensation Reflected in Consolidated Statement of Operations

Share-based compensation was reflected in the consolidated statements of operations as follows (in thousands):

 

 

 

2018

 

 

2017

 

 

2016

 

Cost of revenues

 

$

543

 

 

$

1,050

 

 

$

745

 

General and administrative expense

 

 

2,256

 

 

 

2,721

 

 

 

2,110

 

Research and development expense

 

 

355

 

 

 

679

 

 

 

504

 

 

 

$

3,154

 

 

$

4,450

 

 

$

3,359

 

Schedule of Fair Value of Stock Options Estimated on Grant Date The fair value of stock options is estimated on the grant date using the Black-Scholes option valuation model and the following weighted-average assumptions:

 

 

 

2018

 

 

2017

 

 

2016

 

Expected life (in years)

 

 

7.0

 

 

 

7.0

 

 

 

7.0

 

Risk free interest rate

 

 

2.8

%

 

 

2.2

%

 

 

1.5

%

Volatility

 

 

72.7

%

 

 

79.5

%

 

 

80.1

%

Dividend yield

 

 

%

 

 

%

 

 

%

Summary of Stock Option Activity

The following table summarizes our stock option activity for the year ended October 31, 2018:

 

 

 

 

 

 

 

Weighted-

Average

Option

 

Options

 

Shares

 

 

Price

 

Outstanding as of October 31, 2017

 

 

309,950

 

 

$

23.81

 

Granted

 

 

54,503

 

 

$

1.78

 

Canceled

 

 

(40,967

)

 

$

100.85

 

Outstanding as of October 31, 2018

 

 

323,486

 

 

$

10.34

 

Summary of Information about Stock Options Outstanding and Exercisable

The following table summarizes information about stock options outstanding and exercisable as of October 31, 2018:

 

 

 

Options Outstanding

 

 

Options Exercisable

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

Weighted

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Remaining

 

 

Average

 

 

 

 

 

 

Average

 

Range of

 

Number

 

 

Contractual

 

 

Exercise

 

 

Number

 

 

Exercise

 

Exercise Prices

 

outstanding

 

 

Life

 

 

Price

 

 

exercisable

 

 

Price

 

$0.00 — $3.23

 

 

158,322

 

 

 

8.8

 

 

$

1.60

 

 

 

103,819

 

 

$

1.50

 

$3.24 — $61.20

 

 

165,164

 

 

 

4.1

 

 

$

18.72

 

 

 

163,500

 

 

$

18.79

 

 

 

 

323,486

 

 

 

6.4

 

 

$

10.34

 

 

 

267,319

 

 

$

12.07

 

Summary of RSA and RSU Activity

The following table summarizes our RSA and RSU activity for the year ended October 31, 2018:

 

 

 

 

 

 

 

Weighted-

Average

 

Restricted Stock Awards and Units

 

Shares

 

 

Fair Value

 

Outstanding as of October 31, 2017

 

 

3,008,686

 

 

 

2.52

 

Granted

 

 

2,545,715

 

 

 

1.75

 

Vested

 

 

(925,662

)

 

 

2.80

 

Forfeited

 

 

(258,164

)

 

 

2.19

 

Outstanding as of October 31, 2018

 

 

4,370,575

 

 

 

2.03

 

Fair Value of Shares Issued under Previous Employee Stock Purchase Plan Determined at Grant Date The fair value of shares issued under the previous Employee Stock Purchase Plan was determined at the grant date using the Black-Scholes option-pricing model with the following weighted average assumptions for the years ended October 31, 2017 and 2016:

 

 

 

2017

 

 

2016

 

Expected life (in years)

 

 

0.5

 

 

 

0.5

 

Risk free interest rate

 

 

0.46

%

 

 

0.30

%

Volatility

 

 

75.0

%

 

 

37.0

%

Dividends yield

 

—%

 

 

—%